Company Info
Skyhawk
Drug Discovery & Development
Overview
Skyhawk Therapeutics is committed to discovering, developing and commercializing therapies that use its novel STAR* (Small molecule Therapies for Alternative splicing in RNA) platform to build small molecule drugs that bring breakthrough treatments to patients.
3 Contributions1 / 1
Failed to load
Hematologic
Skyhawk Therapeutics to Present Preclinical Data of SKY-1214 Combination Treatment in Hematologic Cancers
Skyhawk
PR-11-24-NI-118Nov 21, 2024
Failed to load
Clinical Data
Skyhawk Therapeutics Presents Compelling Preclinical Data at the Molecular Targets and Cancer Therapeutics Symposium
Skyhawk
PR-10-24-NI-62Oct 25, 2024
Failed to load
Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform
Skyhawk
PA4048Jun 28, 2018
1 / 1
0 Contributors1 / 0
No authors found
1 / 0